Electroacupuncture (EA) Promotes Gastrointestinal Functional Recovery After Radical Colorectal Cancer Surgery

Launched by SHANGHAI YUEYANG INTEGRATED MEDICINE HOSPITAL · Nov 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying the effects of electroacupuncture, a therapy that uses small electrical currents in combination with acupuncture needles, on helping patients recover their digestive function after having surgery for colorectal cancer. The main goal is to see if this treatment can speed up how quickly patients' gastrointestinal systems start working again after surgery and to ensure that it is safe for them to use.

To participate, individuals must be between 18 and 79 years old, have been diagnosed with colorectal cancer, and be scheduled for surgery. The trial will involve three groups: one will receive standard care after surgery, another will get standard care plus electroacupuncture, and the last group will receive a sham treatment that mimics acupuncture without actually providing the benefits. Participants can expect to receive treatment starting within six hours after their surgery, and the study will last until they either recover their digestive function or for four days post-surgery. This trial aims to provide valuable insights into how electroacupuncture might help improve recovery for patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Surgical patients who meet the diagnostic criteria for colorectal cancer and require elective radical colorectal cancer surgery;
• • 2. 18 years old ≤ age ≤ 79 years old, with no restriction on gender;
• • 3. Understand, agree to participate in this study and sign the informed consent form;
• • 4. American society of Aneshesiologists (ASA) classification I to III.
• Exclusion Criteria:
• • 1. Patients with psychiatric disorders;
• • 2. Patients who have participated or are participating in other clinical studies in the 3 months prior to enrollment;
• • 3. Patients with severe malnutrition (NRS2002 score ≥ 3);
• • 4. Patients with total colectomy;
• • 5. Patients undergoing ileal diversion for rectal cancer;
• • 6. Patients with tumor infiltration requiring resection of other organs;
• • 7. Prophylactic fistulae.
• • Anyone who meets any of the above criteria will be excluded from the study.